Sabra Healthcare REIT, Inc.
SBRAReal Estate Reit Healthcare Facilities
Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024.
- Revenue
- +31.3%
- EPS
- +22.2%
- Free cash flow
- n/m
- Total debt
- −5.99%
Quarter to September 2026, against a year earlier
After hours trading: 20.39, unchanged, last trade 4:01pm Eastern.
Follow SBRA
Alert me
Where the cash went Fiscal 2025, year to Dec 31, 2025
Free cash flow was −$57.2M: capital expenditures were more than operating cash flow. Cash rose by $11.8M. What is a cash flow statement?
- Free cash flow
- −$57.2M −16.4% of operating cash flow
- Returned to shareholders
- $289.5M
- Debt, net
- $107.7M borrowed
- Change in cash
- +$11.8M over the period
| Operating cash flow | 348.6 |
|---|---|
| Capital expenditures | −405.8 |
| Free cash flow | −57.2 |
| Into investments, net | −1.3 |
| Dividends | −289.5 |
| Shares issued, net | +227.8 |
| Debt raised, net | +107.7 |
| Other | +24.3 |
| Change in cash | 11.8 |
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $176M | $136M | $361M | $372M | $355M | $356M | $316M | $301M | $311M | $349M |
| Capex | −$57M | −$277M | $93M | $252M | −$124M | −$41M | −$59M | $84M | −$95M | −$406M |
| Free cash flow | $119M | −$141M | $454M | $625M | $231M | $315M | $256M | $385M | $215M | −$57M |
Figures in millions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income |
155.51 | 126.71 | 13.76 | (77.60) | (113.26) | 138.42 | 69.02 | 279.12 | 158.37 | 70.21 |
Depreciation & Amortization |
187.00 | 169.62 | 183.09 | 187.78 | 178.99 | 176.74 | 181.55 | 191.38 | 113.88 | 68.47 |
Non Cash Items (Other) |
15.96 | 36.76 | 106.46 | 225.25 | 267.95 | 42.44 | 145.42 | (91.41) | (48.45) | 32.28 |
Accounts Receivable Change |
(11.45) | (15.46) | (11.08) | (6.44) | 8.22 | (6.40) | (9.64) | (6.75) | (16.81) | (2.34) |
Change in payables and accrued liability |
1.60 | (7.09) | 8.34 | (13.25) | 14.48 | 3.66 | (13.87) | (11.74) | (71.20) | 7.31 |
Operating Cash Flow |
348.61 | 310.54 | 300.57 | 315.73 | 356.39 | 354.85 | 372.48 | 360.59 | 135.79 | 175.93 |
Capital expenditures |
(405.82) | (95.14) | 84.24 | (59.37) | (41.38) | (123.55) | 252.46 | 93.35 | (276.62) | (56.58) |
Net Aquisitions |
— | — | — | — | — | — | — | — | 77.86 | — |
Long-Term Investments Change (Net) |
(1.25) | (4.09) | (16.26) | (150.93) | (7.77) | (20.07) | — | (359.77) | (2.75) | (7.35) |
Other investing activities |
29.11 | (9.77) | 35.15 | (5.94) | (287.05) | 7.17 | 10.38 | 7.93 | 18.95 | 206.29 |
Investing cash flow |
(377.96) | (109.00) | 103.13 | (216.25) | (336.20) | (136.45) | 262.84 | (258.49) | (182.56) | 142.36 |
Repayment/Issuance of Debt (Net) |
107.72 | 12.56 | (94.13) | 122.78 | 23.86 | (3.07) | (833.66) | (157.34) | 429.86 | (174.41) |
Equity Repurchase (Common, Net) |
227.78 | 86.12 | (2.68) | (4.81) | 308.71 | 80.09 | 549.33 | (0.50) | 366.80 | (1.29) |
Equity Repurchase (Preffered, Net) |
— | — | — | — | — | — | — | (143.75) | — | — |
Dividends Paid (Total) |
(289.50) | (280.15) | (277.45) | (277.16) | (262.92) | (278.30) | (335.43) | (325.22) | (182.09) | (119.26) |
Other financial activities |
(5.24) | (0.09) | (36.04) | (2.52) | (39.51) | (0.83) | (26.42) | (2.54) | (15.75) | (5.94) |
Financing cash flow |
40.76 | (181.56) | (410.30) | (161.71) | 30.14 | (202.11) | (646.18) | (629.34) | 598.82 | (300.90) |
Exchange Rate Adjustment |
0.39 | (0.36) | (0.61) | 0.27 | 0.03 | 0.09 | 0.35 | (0.54) | 0.74 | 0.03 |
Change in Cash |
11.80 | 19.62 | (7.21) | (61.95) | 50.36 | 16.38 | (10.51) | (527.79) | 552.78 | 17.42 |
Beginning Cash |
66.34 | 46.72 | 53.93 | 115.89 | 65.52 | 49.14 | 59.66 | 587.45 | 34.67 | 17.25 |
Ending Cash |
78.14 | 66.34 | 46.72 | 53.93 | 115.89 | 65.52 | 49.14 | 59.66 | 587.45 | 34.67 |
Stock Based Compensation |
11.36 | 8.99 | 7.92 | 7.45 | 7.91 | 7.91 | 9.82 | 7.65 | 8.36 | 7.50 |
Dividends Paid (Common) |
(289.50) | (280.15) | (277.45) | (277.16) | (262.92) | (278.30) | (335.43) | (325.22) | (182.09) | (119.26) |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Assets Liabilities Change (Total) |
(9.85) | (22.55) | (2.73) | (19.69) | 22.70 | (2.74) | (23.51) | (18.50) | (88.01) | 4.97 |
Investments Change (Net) |
(1.25) | (4.09) | (16.26) | (150.93) | (7.77) | (20.07) | — | (359.77) | (2.75) | (7.35) |
Issuance/Purchase of Shares |
227.78 | 86.12 | (2.68) | (4.81) | 308.71 | 80.09 | 549.33 | (144.25) | 366.80 | (1.29) |
| Other line items | ||||||||||
Revenue per Employee |
13.36 | 14.06 | 13.49 | 14.88 | 13.56 | 15.75 | 19.46 | 20.11 | 6.69 | 18.61 |